Come up with a name for your new list and we'll add to it:
ImaRx Therapeutics was acquired by
Coronado Venture Fund on June 21, 1999.
We are a biopharmaceutical company developing and commercializing therapies for vascular disorders. Our research and development efforts are focused on therapies for stroke and other vascular disorder…